glp-1 bmi agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis GLP-1 medications are transforming medical
Description
Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
Patients weigh themselves at least once a week and have monthly visits
Watch Out for Hidden Sugars: Even healthy-sounding drinks can have hidden sugars
Semaglutide replaces this with arginine
32 and 33a)
Both therapies converge on the same cellular signaling pathways, and their combined effect may be greater than the sum of their parts
